BioNexus Gene Lab (BGLC) Times Interest Earned (2018 - 2026)

BioNexus Gene Lab (BGLC) has 9 years of Times Interest Earned data on file, last reported at -$0.04 in Q1 2026.

• For the quarter ending Q1 2026, Times Interest Earned rose 27.94% year-over-year to -$0.04; the trailing twelve-month figure through Mar 2026 stood at -$0.24 (down 12.64% YoY), and the FY2025 full-year result was -$0.26, up 99.08% from the prior year.
• Times Interest Earned eased to -$0.04 in Q1 2026, from $24.53 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $89.48 in Q2 2023 to a low of -$593.69 in Q3 2023.
• A 5-year average of -$38.9 and a median of -$0.06 in 2025 frame the typical range for Times Interest Earned.
• Peak annual rise in Times Interest Earned reached 250.41% in 2023, while the deepest fall reached 1986.25% in 2023.
• Tracing BGLC's Times Interest Earned over 5 years: stood at $25.76 in 2022, then soared by 139.17% to $61.62 in 2023, then sank by 147.66% to -$29.37 in 2024, then surged by 183.51% to $24.53 in 2025, then tumbled by 100.18% to -$0.04 in 2026.
• Business Quant data shows BGLC's Times Interest Earned at -$0.04 in Q1 2026, $24.53 in Q4 2025, and -$12.87 in Q3 2025.